Acetadote is used in hospital emergency departments to prevent or lessen the risk of liver damage following an acetaminophen overdose, which is often caused by overuse of over-the-counter pain ...

Acetadote is an intravenous (IV) formulation of N-acetylcysteine (NAC) indicated to prevent or lessen liver injury after ingestion of potentially toxic quantities of acetaminophen1. Acetaminophen ...

Acetadote is supplied as a 20% solution (200mg/mL) in a 30mL single-dose vial that must be diluted prior to intravenous administration. Total injection volume will vary based on the patient’s ...

Thanks mostly to FDA approval of a supplementary New Drug Application (sNDA) for Acetadote (N-acetylcysteine for injection), Cumberland stock has been on a monumental run in December 2024.

Shares of Cumberland Pharmaceuticals (CPIX) doubled on Tuesday morning, reaching levels not seen since March 2023, following FDA approval of a new dosing regimen for its liver drug, Acetadote.

The FDA approved a supplemental NDA for Acetadote, an antidote for acetaminophen overdose indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of ...

Credit: Getty Images. The newly approved regimen is expected to simplify administration and potentially reduce medication errors and dose-related reactions. Certain factors should be considered ...